FindMyKOL
Clinical trialNCT05906303UnknownPhase 1Interventional

Caffeine in the Second Stage of Labor in Low-risk Nulliparous Mothers at Term

SponsorThe Reading Hospital and Medical CenterEnrollment80Second Stage of Labor
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Single blind, randomized control trial to determine benefit of caffeine and sodium benzoate on the second stage of labor
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Reading Hospital Labor & Delivery

    West Reading, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Benzoate / caffeineNormal Saline
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Dec 2023
Primary completion
1 Dec 2024
Completion
1 Feb 2025
Last update posted
14 Sept 2023
Registered enrollment
80
Registry id
NCT05906303
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.